Raindrop Near Vision Inlay

Implant, Corneal, Refractive

FDA Premarket Approval P150034

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the raindrop® near vision inlay. This device is indicated for intrastromal implantation to improve near vision in the non-dominant eye of phakic, presbyopic patients, 41 to 65 years of age, who have manifest refractive spherical equivalent of (mrse) +1. 00 diopters (d) to -0. 50 d with less than or equal to 0. 75 d of refractive cylinder, who do not require correction for clear distance vision, but who do require near correction of +1. 50 d to +2. 50 d of reading add.

DeviceRaindrop Near Vision Inlay
Classification NameImplant, Corneal, Refractive
Generic NameImplant, Corneal, Refractive
ApplicantRVO 2.0, Inc. (d.b.a. Optics Medical)
Date Received2015-09-24
Decision Date2016-06-29
Notice Date2016-07-08
PMAP150034
SupplementS
Product CodeLQE
Docket Number16M-1837
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address RVO 2.0, Inc. (d.b.a. Optics Medical) 65 Enterprise Suite 455 aliso Viejo, CA 92656
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150034Original Filing
S009 2021-12-09 Normal 180 Day Track No User Fee
S008 2019-08-19 Normal 180 Day Track No User Fee
S007 2017-12-21 Normal 180 Day Track No User Fee
S006 2017-12-18 30-day Notice
S005 2017-09-29 Normal 180 Day Track
S004 2017-09-29 30-day Notice
S003 2017-02-03 Special (immediate Track)
S002 2016-07-29 Normal 180 Day Track No User Fee
S001 2016-07-29 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.